NATCO PHARMA
|
NATCO PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹2,216 Cr | ₹2,084 Cr | ₹2,058 Cr | ₹2,285 Cr | ₹2,202 Cr |
Sales | ₹1,947 Cr | ₹1,697 Cr | ₹1,856 Cr | ₹2,230 Cr | ₹2,161 Cr |
Job Work/ Contract Receipts | ₹4.60 Cr | ₹10 Cr | ₹30 Cr | ₹15 Cr | ₹6.20 Cr |
Processing Charges / Service Income | ₹225 Cr | ₹15 Cr | ₹145 Cr | ₹6.80 Cr | ₹6.60 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹40 Cr | ₹362 Cr | ₹27 Cr | ₹33 Cr | ₹28 Cr |
Less: Excise Duty | - | - | - | - | ₹17 Cr |
Net Sales | ₹1,945 Cr | ₹2,052 Cr | ₹1,915 Cr | ₹2,095 Cr | ₹2,185 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-17 Cr | ₹-48 Cr | ₹-75 Cr | ₹-34 Cr | ₹-25 Cr |
Raw Material Consumed | ₹545 Cr | ₹532 Cr | ₹430 Cr | ₹367 Cr | ₹436 Cr |
Opening Raw Materials | ₹337 Cr | ₹160 Cr | ₹211 Cr | ₹157 Cr | ₹111 Cr |
Purchases Raw Materials | ₹393 Cr | ₹522 Cr | ₹251 Cr | ₹365 Cr | ₹437 Cr |
Closing Raw Materials | ₹244 Cr | ₹337 Cr | ₹160 Cr | ₹211 Cr | ₹157 Cr |
Other Direct Purchases / Brought in cost | ₹59 Cr | ₹187 Cr | ₹128 Cr | ₹55 Cr | ₹46 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹76 Cr | ₹61 Cr | ₹62 Cr | ₹60 Cr | ₹56 Cr |
Electricity & Power | ₹76 Cr | ₹61 Cr | ₹62 Cr | ₹60 Cr | ₹56 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹445 Cr | ₹415 Cr | ₹375 Cr | ₹356 Cr | ₹326 Cr |
Salaries, Wages & Bonus | ₹391 Cr | ₹353 Cr | ₹313 Cr | ₹287 Cr | ₹266 Cr |
Contributions to EPF & Pension Funds | ₹26 Cr | ₹24 Cr | ₹22 Cr | ₹20 Cr | ₹17 Cr |
Workmen and Staff Welfare Expenses | ₹14 Cr | ₹14 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr |
Other Employees Cost | ₹14 Cr | ₹24 Cr | ₹25 Cr | ₹35 Cr | ₹29 Cr |
Other Manufacturing Expenses | ₹354 Cr | ₹292 Cr | ₹243 Cr | ₹276 Cr | ₹183 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹60 Cr | ₹54 Cr | ₹51 Cr | ₹47 Cr | ₹64 Cr |
Packing Material Consumed | ₹33 Cr | ₹28 Cr | ₹27 Cr | ₹22 Cr | - |
Other Mfg Exp | ₹261 Cr | ₹210 Cr | ₹165 Cr | ₹208 Cr | ₹119 Cr |
General and Administration Expenses | ₹153 Cr | ₹117 Cr | ₹133 Cr | ₹126 Cr | ₹106 Cr |
Rent , Rates & Taxes | ₹39 Cr | ₹37 Cr | ₹40 Cr | ₹42 Cr | ₹28 Cr |
Insurance | ₹26 Cr | ₹20 Cr | ₹15 Cr | ₹10 Cr | ₹9.80 Cr |
Printing and stationery | - | - | - | - | ₹8.00 Cr |
Professional and legal fees | ₹49 Cr | ₹30 Cr | ₹36 Cr | ₹34 Cr | ₹22 Cr |
Traveling and conveyance | ₹22 Cr | ₹16 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr |
Other Administration | ₹39 Cr | ₹30 Cr | ₹42 Cr | ₹41 Cr | ₹38 Cr |
Selling and Distribution Expenses | ₹44 Cr | ₹34 Cr | ₹98 Cr | ₹90 Cr | ₹137 Cr |
Advertisement & Sales Promotion | ₹33 Cr | ₹21 Cr | ₹94 Cr | ₹85 Cr | ₹131 Cr |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹11 Cr | ₹13 Cr | ₹4.50 Cr | ₹5.30 Cr | ₹6.20 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹82 Cr | ₹46 Cr | ₹67 Cr | ₹59 Cr | ₹39 Cr |
Bad debts /advances written off | ₹20 Cr | ₹12 Cr | ₹5.50 Cr | ₹2.00 Cr | ₹13 Cr |
Provision for doubtful debts | ₹27 Cr | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | ₹2.20 Cr | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹35 Cr | ₹34 Cr | ₹61 Cr | ₹55 Cr | ₹25 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹1,681 Cr | ₹1,448 Cr | ₹1,332 Cr | ₹1,300 Cr | ₹1,256 Cr |
Operating Profit (Excl OI) | ₹264 Cr | ₹604 Cr | ₹583 Cr | ₹795 Cr | ₹928 Cr |
Other Income | ₹99 Cr | ₹106 Cr | ₹107 Cr | ₹130 Cr | ₹40 Cr |
Interest Received | ₹39 Cr | ₹57 Cr | ₹79 Cr | ₹90 Cr | ₹25 Cr |
Dividend Received | ₹0.20 Cr | - | - | - | ₹0.20 Cr |
Profit on sale of Fixed Assets | ₹43 Cr | ₹32 Cr | ₹16 Cr | ₹14 Cr | ₹10 Cr |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | ₹2.40 Cr | ₹2.90 Cr | - | ₹0.50 Cr |
Foreign Exchange Gains | ₹10 Cr | ₹4.00 Cr | ₹5.10 Cr | ₹25 Cr | ₹3.40 Cr |
Others | ₹6.80 Cr | ₹11 Cr | ₹4.00 Cr | ₹2.00 Cr | ₹1.10 Cr |
Operating Profit | ₹363 Cr | ₹710 Cr | ₹690 Cr | ₹925 Cr | ₹969 Cr |
Interest | ₹18 Cr | ₹13 Cr | ₹22 Cr | ₹19 Cr | ₹15 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | ₹13 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹4.50 Cr | ₹4.00 Cr | ₹3.80 Cr | ₹3.10 Cr | ₹2.20 Cr |
Other Interest | ₹13 Cr | ₹9.30 Cr | ₹18 Cr | ₹16 Cr | - |
PBDT | ₹345 Cr | ₹697 Cr | ₹669 Cr | ₹906 Cr | ₹953 Cr |
Depreciation | ₹143 Cr | ₹117 Cr | ₹100 Cr | ₹81 Cr | ₹66 Cr |
Profit Before Taxation & Exceptional Items | ₹202 Cr | ₹580 Cr | ₹569 Cr | ₹825 Cr | ₹887 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹202 Cr | ₹580 Cr | ₹569 Cr | ₹825 Cr | ₹887 Cr |
Provision for Tax | ₹32 Cr | ₹137 Cr | ₹111 Cr | ₹182 Cr | ₹192 Cr |
Current Income Tax | ₹48 Cr | ₹141 Cr | ₹127 Cr | ₹188 Cr | ₹220 Cr |
Deferred Tax | ₹40 Cr | ₹14 Cr | ₹18 Cr | ₹-6.00 Cr | ₹-28 Cr |
Other taxes | ₹-56 Cr | ₹-18 Cr | ₹-34 Cr | - | - |
Profit After Tax | ₹170 Cr | ₹442 Cr | ₹458 Cr | ₹642 Cr | ₹695 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | ₹-1.50 Cr | ₹2.70 Cr | ₹2.00 Cr | ₹1.00 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹170 Cr | ₹441 Cr | ₹461 Cr | ₹644 Cr | ₹696 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹2,568 Cr | ₹2,239 Cr | ₹1,937 Cr | ₹1,412 Cr | ₹909 Cr |
Appropriations | ₹2,738 Cr | ₹2,680 Cr | ₹2,398 Cr | ₹2,056 Cr | ₹1,606 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | ₹22 Cr | ₹19 Cr | ₹31 Cr |
Other Appropriation | ₹-11 Cr | ₹16 Cr | ₹14 Cr | ₹8.50 Cr | - |
Equity Dividend % | ₹225.00 | ₹262.50 | ₹337.50 | ₹312.50 | ₹412.50 |
Earnings Per Share | ₹9.32 | ₹24.16 | ₹25.32 | ₹35.31 | ₹37.73 |
Adjusted EPS | ₹9.32 | ₹24.16 | ₹25.32 | ₹35.31 | ₹37.73 |
Compare Income Statement of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹17,900.1 Cr | 0.8% | -6.7% | 74% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 0.8% |
-6.7% |
74% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses